Carmegliptin - CISMeF

Preferred Label : Carmegliptin;

NCIt synonyms : (4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1- a]isoquinolin-3-yl]-4-(fluoromethyl)pyrrolidin-2-one;

NCIt definition : A potent, long-acting, selective, orally bioavailable, pyrrolidinone-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Carmegliptin shows extensive tissue distribution and is excreted unchanged in the urine and bile.;

UNII : 9Z723VGH7J;

InChIKey : GUYMHFIHHOEFOA-ZCPGHIKRSA-N;

CAS number : 813452-18-5;

Molecule name : RO4876904; R1579;

Chemical formula : C20H28FN3O3;

Details

Origin ID

C81698;

UMLS CUI

C2825730;

Currated CISMeF NLP mapping
- carmegliptin [MeSH concept]
- carmegliptin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- carmegliptin [MeSH Supplementary Concept]
- carmegliptin [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Carmegliptin Dihydrochloride [NCIt concept]
is_free_acid_or_base_form_of
- Carmegliptin Dihydrochloride [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients